DDIT3 and diffuse large B-cell lymphoma: These results fit perfectly with a randomized controlled trial published by Martinelli et al, in which 45 patients with primary gastric DLBCL were randomly assigned to RT or another 2 cycles of CHOP when they achieved CR after 4–6 cycles of CHOP.